Lower Urinary Tract Symptoms (LUTS) are frequently present in the general population as
patients age with approximately a third of individuals experiencing LUTS during their …

Methylene Blue (MB), following its introduction to biology in the 19th century by Ehrlich, has
found uses in various areas of medicine and biology. At present, MB is the first line of …

Mitochondrial dysfunction plays a central role in the formation of neuroinflammation and
oxidative stress, which are important factors contributing to the development of brain …

Monoamine oxidase inhibitors (MAOI) are a class of drugs that were originally developed for
the treatment of depression but have since been expanded to be used in management of …

With the increase in life expectancy registered in the past few decades, the prevalence of
various medical conditions related to aging has been observed, such as dementia and …

Neuroprotective strategies, including free radical scavengers, ion channel modulators, and
anti-inflammatory agents, have been extensively explored in the last 2 decades for the …

Methylene blue (MB) is a well-established drug with a long history of use, owing to its
diverse range of use and its minimal side effect profile. MB has been used classically for the …

The relationship between methylene blue (MB) and Alzheimer's disease (AD) has recently
attracted increasing scientific attention since it has been suggested that MB may slow down …

Background and purpose: Monoamine oxidase inhibitors (MAOI) are known to cause
serotonin toxicity (ST) when administered with selective serotonin reuptake inhibitors (SSRI) …

Methylene blue (MB) has been used clinically for about a century to treat numerous
ailments. We show that MB and other diaminophenothia‐zines extend the life span of …